Physician-pharmacist collaborative intervention in the drug therapy optimization in patients with type 2 diabetes (2013)
- Authors:
- USP affiliated authors: STORPIRTIS, SILVIA - FCF ; DOREA, EGIDIO LIMA - HU ; PINTO, GELBA ALMEIDA - HU ; GUSUKUMA, MARIA CECILIA - HU
- Unidades: FCF; HU
- Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; FÁRMACOS
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Clinical Pharmacy
- ISSN: 2210-7703
- Volume/Número/Paginação/Ano: v. 35, n. 6, p. 1314-1315 res. HP-PC103, 2013
- Conference titles: ESCP Symposium on Clinical Pharmacy: Implementation of Pharmacy Practice
-
ABNT
AGUIAR, Patrícia Melo et al. Physician-pharmacist collaborative intervention in the drug therapy optimization in patients with type 2 diabetes. International Journal of Clinical Pharmacy. Dordrecht: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 out. 2024. , 2013 -
APA
Aguiar, P. M., Dórea, E. L., Pinto, G. A., Gusukuma, M. C., Lyra Júnior, D. P. de, & Storpirtis, S. (2013). Physician-pharmacist collaborative intervention in the drug therapy optimization in patients with type 2 diabetes. International Journal of Clinical Pharmacy. Dordrecht: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Aguiar PM, Dórea EL, Pinto GA, Gusukuma MC, Lyra Júnior DP de, Storpirtis S. Physician-pharmacist collaborative intervention in the drug therapy optimization in patients with type 2 diabetes. International Journal of Clinical Pharmacy. 2013 ; 35( 6): 1314-1315 res. HP-PC103.[citado 2024 out. 02 ] -
Vancouver
Aguiar PM, Dórea EL, Pinto GA, Gusukuma MC, Lyra Júnior DP de, Storpirtis S. Physician-pharmacist collaborative intervention in the drug therapy optimization in patients with type 2 diabetes. International Journal of Clinical Pharmacy. 2013 ; 35( 6): 1314-1315 res. HP-PC103.[citado 2024 out. 02 ] - Critério de Beers: Avaliação de prescrições para pacientes renais crônicos ambulatoriais
- Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe
- Impact of cholesterol-lowering therapies on gene expression of adhesion molecules in mononuclear cells from hypercholesterolemic patients
- Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study
- Pharmacist intervention in the drug therapy optimization in patients with poorly controlled type 2 diabetes
- Atenção farmacêutica ambulatorial ao paciente renal crônico no Hospital Universitário da USP (HU-USP)
- Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients
- Downregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol
- Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients
- Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas